Purpose The aim of this study was to update the clinical practice guidelines for the use of
basic oral care (BOC) interventions for the prevention and/or treatment of oral mucositis …

Mucositis is a common complication of chemotherapy, radiotherapy and targeted agents. It
often affects compliance to anticancer therapies as it frequently causes schedule delays …

Aim The ulcerative phase of oral mucositis following radiotherapy/chemotherapy for oral
cancer colonizes bacteria, fungi and viruses. The role of a microbiota, specifically bacterial …

Chemotherapy—induced gastrointestinal dysfunction is a common occurrence associated
with many different classes of chemotherapeutic agents. Gastrointestinal toxicity includes …

With the rapid development of metagenomic high-throughput sequencing technology, more
and more oral mucosal diseases have been proven to be associated with oral microbiota …

Mucositis is one of the most common debilitating side effects related to chemotherapy (CT),
radiation therapy (RT), targeted agents and immunotherapy. It is a complex process …

Purpose Oral mucositis (OM) remains a significant complication developed by many patients
undergoing radiotherapy (RT) to the head and neck region. Emerging data suggest oral …

Oral mucositis (OM) is one of the most common and debilitating oral complications of cancer
treatments including chemotherapy, radiotherapy, and hematopoietic stem cell …

The aim of this prospective, two center study was to investigate the dynamics of the microbial
changes in relation to the development of ulcerative oral mucositis in autologous SCT …

Background: Oropharyngeal mucositis occurs in virtually all patients with head and neck
cancer receiving radiochemotherapy. The manipulation of the oral cavity microbiota …